Equites Radar

WRBY · Warby Parker Inc.

Medical Instruments & SuppliesUnited StatesAnalyst view: Buy

$24.71

+1.69% last session

End-of-day data · close of 2026-09-11

Mildly bearish1 bullish · 3 bearish technical signals
Consensus: Buy (1.71 from 13 analysts)
To mean target: +25.3%

Market cap

$3B

Enterprise value

$3B

Trailing P/E

405.0

Forward P/E

39.5

Dividend yield

Beta

1.91

Avg volume

3M

Employees

2K

Daily Change %

1.69%

5 Days Change

0.90%

10 Days Change

-0.12%

30 Days Change

-1.88%

60 Days Change

-15.42%

Month to Day Change

1.57%

Year to Day Change

12.76%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.71
Covering analysts13
Mean price target$30.46
Low price target$24.00
Upside to mean target+25.3%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)45.6
50-day MA$26.25
200-day MA$24.98
Price vs 50-day MA-5.9%
Price vs 200-day MA-1.1%
MACD histogram-0.04
Volume vs 3-month avg0.6×
52w low $16.4952w high $30.34

Analyst sentiment over time — WRBY

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-08-07

Latest call per bank · past 12 months

UBS

Neutral

$28.00

+15.2% vs price
▲ raised from $27.00Maintains · 2026-08-07

Bank of America

Buy

$33.00

+35.8% vs price
▲ raised from $0.00Initiates · 2026-06-29

Citigroup

Neutral

$24.00

-1.2% vs price
▲ raised from $18.00Maintains · 2026-03-17

Goldman Sachs

Buy

$31.00

+27.6% vs price
▲ raised from $27.00Maintains · 2025-10-06

Recent rating actions

DateFirmActionRatingPrice target
2026-08-07UBSMaintainsNeutral$27.00 $28.00
2026-08-07CitizensMaintainsMarket Outperform$30.00 $29.00
2026-06-29Bank of AmericaInitiatesBuy$0.00 $33.00
2026-05-08UBSMaintainsNeutral$25.00 $27.00
2026-05-07BTIGMaintainsBuy$32.00 $34.00
2026-03-17CitigroupMaintainsNeutral$18.00 $24.00
2026-02-20Telsey Advisory GroupMaintainsOutperform$32.00
2026-02-10Telsey Advisory GroupMaintainsOutperform$32.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 46 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 5.9% below the 50-day MA ($26.25).
  • Price vs 200-day MA: Trading 1.1% below the 200-day MA ($24.98).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.04) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($16.49) and high ($30.34).

WRBY Price Chart

Loading chart for WRBY

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$3.06
Net Debt / EBITDA-1.0
WACC17.0%
Revenue growth10.00%
Earnings growth

About Warby Parker Inc.

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

More in Medical Instruments & Supplies

Screen WRBY against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.